The Rise of Synthetic Peptides: Unproven Benefits and Serious Risks

Synthetic peptides are gaining popularity among biohackers and wellness influencers who use them, often via injection, for enhanced athletic performance and optimized health. While some synthetic peptides like insulin and active ingredients in GLP-1 obesity drugs are FDA-approved medicines, many of the peptides available for purchase online are experimental with unproven benefits.

Scientific Scrutiny and Potential Harms

Paul Knoepfler, a cell and molecular biologist at the University of California, Davis, states that most research on these experimental peptides has been conducted in animals or labs, not humans. He notes that while the science behind some applications can be theoretically sound, using untested peptides carries risks of serious harm.

For instance, some animal studies suggest BPC-157 may aid tissue repair by accelerating blood vessel growth; however, Knoepfler cautions that this could also theoretically encourage the growth of pre-cancerous cells. He emphasizes the necessity of clinical trials to confirm any positive or negative effects.

Knoepfler also highlights that the therapeutic dose for these substances is often unknown, and the doses people are taking frequently lack scientific basis. He strongly advises consulting a physician before trying any peptides.

Medical Practice and Regulatory Oversight

Dr. Amanda Kahn, who runs a medical practice, reports that some patients seek her opinion on peptides for conditions like inflammation or chronic pain. She may prescribe them as an adjunct therapy, ensuring patients understand their experimental nature and avoiding overpromising a cure-all.

Many individuals acquire and inject peptides without medical supervision, often purchasing "research-grade" products online that are explicitly labeled as not for pharmaceutical use. Kahn and Knoepfler warn that these products may contain toxic solutions or contaminants. Doctors prescribing peptides typically refer patients to compounding pharmacies, which prepare tailored versions of drugs.

Howard Sklamberg, a former FDA deputy commissioner, points out that compounding pharmacies generally operate under different regulations than drug manufacturers, potentially increasing the risk of compounded products, especially when produced in large quantities. Conversely, Scott Brunner of the Alliance for Pharmacy Compounding maintains that state boards license and inspect these pharmacies, providing rigorous oversight for individual patient prescriptions.

Navigating the "Wild West" of Online Peptides

The FDA has stated it is working to list bulk drug substances for compounding, and certain peptides are currently on an FDA list of substances with "significant safety concerns."

Howard Sklamberg describes the online marketplace for peptides as a "wild west."

He notes that products marketed as supplements could be considered unregulated drugs, making it challenging for the FDA to address all non-compliant sellers due to the sheer volume of online retail.

Conclusion: A Gamble with Unknowns

While some popular peptides marketed online may have potential health and wellness benefits, most lack sufficient human studies regarding efficacy and safety, making their use a gamble. Consulting a physician and sourcing peptides from a reputable compounding pharmacy can reduce some immediate risks, but these experimental drugs have largely unknown long-term health consequences.